ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
biomarin
An Associate Director, Market Access Strategy at BioMarin develops and executes US market access strategies to enable timely and sustainable patient access, coverage, and reimbursement for 2-3 disease areas within the Enzyme Therapies BU.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
biomarin didn’t post a salary, so this is our estimate from similar listings.
Director, Global Market Access
Alnylam Pharmaceuticals
Director, Global Value & Market Access
Alfasigma
Senior Vice President (SVP) of Market Access
Tango Therapeutics
Senior Manager, Field Economics, THV, ANZ
Edwards Lifesciences
Director, Value & Access
Leica Biosystems
Director, Value Market Access Strategy & Marketing
Iovance Biotherapeutics